Singson, Giselle L.

HRN: 22-50-82  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2023
CEFUROXIME 1.5GM (VIAL)
01/26/2023
01/26/2023
IVT
1.5g
Now
UTI
Waiting Final Action 
01/26/2023
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
01/26/2023
02/01/2023
IVT
750mg
Q8
UTI
01/26/2023
CEFTRIAXONE 1G (VIAL)
01/26/2023
02/01/2023
IVT
1g
Q12
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: